Moro ALD - Search Results

1

Human immunodeficiency virus in a cohort of systemic lupus erythematosus patients.

Hax V, Moro ALD, Piovesan RR, Goldani LZ, Xavier RM, Monticielo OA. Hax V, et al. Among authors: moro ald. Adv Rheumatol. 2018 Jul 11;58(1):12. doi: 10.1186/s42358-018-0003-2. Adv Rheumatol. 2018. PMID: 30657064

2

The effects of cultural background on patient-perceived impact of psoriatic arthritis - a qualitative study conducted in Brazil and France.

Palominos PE, Gossec L, Kreis S, Hinckel CL, da Silva Chakr RM, Moro ALD, Campbell W, de Wit M, Goel N, Kohem CL, Xavier RM. Palominos PE, et al. Among authors: moro ald. Adv Rheumatol. 2018 Oct 22;58(1):33. doi: 10.1186/s42358-018-0036-6. Adv Rheumatol. 2018. PMID: 30657095

3

A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.

NIHR Global Health Research Unit on Global Surgery; STARSurg Collaborative. NIHR Global Health Research Unit on Global Surgery, et al. Lancet Digit Health. 2024 Jul;6(7):e507-e519. doi: 10.1016/S2589-7500(24)00065-7. Lancet Digit Health. 2024. PMID: 38906616 Free article.

4

Cachexia in patients with rheumatoid arthritis: a cohort study.

Santo RC, Silva JM, Lora PS, Moro ALD, Freitas EC, Bartikoski BJ, Andrade NP, Palominos PE, Hax V, Fighera TM, Spritzer PM, Brenol CV, Chakr RM, Filippin LI, Baker JF, Xavier RM. Santo RC, et al. Among authors: moro ald. Clin Rheumatol. 2020 Dec;39(12):3603-3613. doi: 10.1007/s10067-020-05119-y. Epub 2020 May 23. Clin Rheumatol. 2020. PMID: 32447598

5

Electroconvulsive therapy as a treatment for refractory neuropsychiatric lupus with catatonia: three case studies and literature review.

Bica BE, Moro AL, Hax V, Nicol NA, Campos GS, Rivera LM, da Costa AF, Xavier RM, Monticielo OA. Bica BE, et al. Lupus. 2015 Oct;24(12):1327-31. doi: 10.1177/0961203315585816. Epub 2015 May 12. Lupus. 2015. PMID: 25972366 Review.

6

Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals.

Zavascki AP, Barth AL, Gaspareto PB, Gonçalves AL, Moro AL, Fernandes JF, Goldani LZ. Zavascki AP, et al. J Antimicrob Chemother. 2006 Oct;58(4):882-5. doi: 10.1093/jac/dkl327. Epub 2006 Aug 8. J Antimicrob Chemother. 2006. PMID: 16895936

7

Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study.

Zavascki AP, Barth AL, Fernandes JF, Moro AL, Gonçalves AL, Goldani LZ. Zavascki AP, et al. Crit Care. 2006;10(4):R114. doi: 10.1186/cc5006. Crit Care. 2006. PMID: 16882337 Free PMC article.

8

The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.

Zavascki AP, Barth AL, Gonçalves AL, Moro AL, Fernandes JF, Martins AF, Ramos F, Goldani LZ. Zavascki AP, et al. J Antimicrob Chemother. 2006 Aug;58(2):387-92. doi: 10.1093/jac/dkl239. Epub 2006 Jun 3. J Antimicrob Chemother. 2006. PMID: 16751638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters